A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Work
Year: 2010
Type: article
Abstract: <h3>Objectives</h3> To assess the efficacy of the interleukin 1 receptor antagonist anakinra in systemic-onset juvenile idiopathic arthritis (SJIA). <h3>Methods</h3> A multicentre, randomised, double-... more
Source: Annals of the Rheumatic Diseases
Institutions Hôpital Necker-Enfants Malades, Hôpital Femme Mère Enfant, Hôpital Pellegrin, Assistance Publique – Hôpitaux de Paris, Université Paris Cité +5 more
Cites: 34
Cited by: 532
Related to: 10
FWCI: 21.47
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze